Europe Biodefense Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

No. of Pages: 105    |    Report Code: TIPRE00010410    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Biodefense Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Biodefense market – By Product

1.3.2        Europe Biodefense market – By Country

2.           Europe Biodefense Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Biodefense market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Biodefense market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Biodefense Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Presence of Favourable Government Initiatives

5.1.2        Increase in the Number of Naturally Occurring Outbreaks

5.1.3        Increasing Threat of Biological Weapons and Nuclear Armed ICBM

5.2         Key Market Restraints

5.2.1        Fluctuations in funding due to the changing EU & government policies

5.3         Key Market Opportunities

5.3.1        Increased Adoption of Technologies

5.4         Future Trends

5.4.1        Predictive Analytics to Reshape Biodefense Market

5.5         Impact Analysis

6.           Biodefense Market – Europe Analysis

6.1         Europe Biodefense Market Revenue Forecasts and Analysis

7.           Europe Biodefense market Analysis And Forecasts To 2027 – By Product

7.1         Overview

7.2         Europe Biodefense market, By Product 2019 & 2027 (%)

7.2.1        Europe Biodefense market Revenue and Forecasts to 2027, By Product (US$ Mn)

7.3         Anthrax

7.3.1        Overview

7.3.2        Europe Anthrax Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Small pox

7.4.1        Overview

7.4.2        Europe Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)

7.5         Botulism

7.5.1        Overview

7.5.2        Europe Botulism Market Revenue and Forecasts to 2027 (US$ Mn)

7.6         Radiation/Nuclear

7.6.1        Overview

7.6.2        Europe Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)

7.7         Others

7.7.1        Overview

7.7.2        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

8.           Biodefense market Revenue and Forecasts To 2027 – Geographical Analysis

8.1         Europe Biodefense market Revenue and Forecasts To 2027

8.1.1        Overview

8.1.2        Europe: Biodefense Market - Revenue and Forecast to 2027 (USD Million)

8.1.3        Europe: Biodefense Market, by Product, 2018–2027 (USD Million)

8.1.4        Europe: Biodefense Market, by Country, 2018 & 2027 (%)

8.1.5        Germany: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.1          Germany: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.5.2          Germany: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.6        UK: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.1          UK: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.6.2          UK: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.7        France: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.1          France: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.7.2          France: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.8        Spain: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.1          Spain: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.8.2          Spain: Biodefense Market, by Product Type, 2018–2027 (USD Million)

8.1.9        Italy: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.1          Italy: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

8.1.9.2          Italy: Biodefense Market, by Product Type, 2018–2027 (USD Million)

9.           Impact 0f Covid-19 Pandemic On Europe Biodefense Market

9.1         Europe: Impact assessment of COVID-19 Pandemic

10.        Europe Biodefense market Industry Landscape

10.1      Overview

10.2      Growth Strategies in The Biodefense Market, 2016-2020

10.3      Inorganic Growth Strategies

10.3.1     Overview

10.4      Organic Growth Strategies

10.4.1     Overview

11.        Company Profiles

11.1      Bavarian Nordic

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Alnylam Pharmaceuticals, Inc.

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      SIGA Technologies

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Emergent BioSolutions Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Cleveland Bio Labs

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe Biodefense market Revenue and Forecasts To 2027, By Product (US$ Mn)

Table 2.             Europe Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.             UK Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 5.             France Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 6.             Spain Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.             Itlay Biodefense Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 8.             Recent Inorganic Growth Strategies In The Biodefense Market

Table 9.             Recent Organic Growth Strategies In The Biodefense Market

Table 10.          Glossary of Terms, Biodefense Market

 


LIST OF FIGURES

Figure 1.           Biodefense market Segmentation

Figure 2.           Europe Biodefense market Overview

Figure 3.           Anthrax Segment Held Largest Share of Product Segment in Biodefense Market

Figure 4.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe Biodefense market- Leading Country Markets (US$ Mn)

Figure 6.           Europe Biodefense market, Industry Landscape

Figure 7.           Biodefense market - Europe PEST Analysis

Figure 8.           Biodefense market Impact Analysis of Drivers and Restraints

Figure 9.           Europe Biodefense market – Revenue Forecasts and Analysis – 2019- 2027

Figure 10.        Europe Biodefense market, By Product 2019 & 2027 (%)

Figure 11.        Europe Anthrax Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe Small Pox Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Europe Botulism Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        Europe Radiation/Nuclear Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe: Biodefense Market, by Key Country – Revenue (2019) (USD Million)

Figure 17.        Europe Biodefense Market Revenue and Forecast to 2027 (USD Million)

Figure 18.        Europe: Biodefense Market, by Country, 2018 & 2027 (%)

Figure 19.        Germany: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 20.        UK: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        France: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Spain: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 23.        Italy: Biodefense Market – Revenue and Forecast to 2027 (USD Million)

Figure 24.        Impact Of Covid-19 Pandemic In European Country Markets

Figure 25.        Growth Strategies in the Biodefense Market, 2016-2020

 

The List of Companies - Europe Biodefense Market

The List of Companies - Europe Biodefense Market

  1. Bavarian Nordic
  2. Alnylam Pharmaceuticals, Inc.
  3. SIGA Technologies
  4. Emergent BioSolutions Inc.
  5. Cleveland Bio Labs
  6. Dynavax Technologies
  7. Elusys Therapeutics, Inc.
  8. Soligenix
  9. Altimmune
  10. Pluristem Therapeutics